Jincaopian not checked

Beijing Konruns Pharmaceutical Co., Ltd. · ZY5301

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Chronic Pelvic Pain (2 trials)
Main trialPhase 3
“The objective of this phase III trial to evaluate the efficacy and safety of Jincaopian Tablets in the treatment of subjects with chronic pelvic pain after pelvic inflammatory disease”In the company’s words, NCT05970783 on ClinicalTrials.gov
Other names
ZY5301

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 3Unknown 11 Mar 2024 A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
Phase 2Completed 30 Nov 2021 The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Jincaopian

Following is part of Solo: you see every change to Jincaopian the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in